 SAN DIEGO, March 29, 2021 PRNewswire -- Evofem Biosciences, Inc. NASDAQ: EVFM today announced the closing of its previously announced underwritten public offering of 17,142,857 shares of its common stock at 1.75 per share. Evofems aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, were 30.0 million. 